Samuel J. Peretsman, MD, discusses which prostate cancers can be treated and which prostate glands can be treated with HIFU, contraindications to the treatment, and what expectations patients need to have postoperatively.
Dr. Badar M. Mian highlights the safety and efficacy of relugolix, describing the drug as an “exciting new option” for patients with recurrent or advanced prostate cancer.
